Search Results

There are 2298 results for: content related to: Probiotic VSL #3-induced TGF -β ameliorates food allergy inflammation in a mouse model of peanut sensitization through the induction of regulatory T cells in the gut mucosa

  1. VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis

    Liver International

    Volume 35, Issue 3, March 2015, Pages: 735–745, Elisabet Sánchez, Juan C. Nieto, Ana Boullosa, Silvia Vidal, Francesc J. Sancho, Giacomo Rossi, Pau Sancho-Bru, Rosa Oms, Beatriz Mirelis, Cándido Juárez, Carlos Guarner and Germán Soriano

    Version of Record online : 12 MAY 2014, DOI: 10.1111/liv.12566

  2. You have free access to this content
    VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice

    Hepatology

    Volume 49, Issue 3, March 2009, Pages: 989–997, Arumugam Velayudham, Angela Dolganiuc, Michael Ellis, Jan Petrasek, Karen Kodys, Pranoti Mandrekar and Gyongyi Szabo

    Version of Record online : 29 DEC 2008, DOI: 10.1002/hep.22711

  3. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 15, Issue 11, November 2009, Pages: 1721–1736, C. Reiff, M. Delday, G. Rucklidge, M. Reid, G. Duncan, S. Wohlgemuth, G. Hörmannsperger, G. Loh, M. Blaut, E. Collie-Duguid, D. Haller and D. Kelly

    Version of Record online : 28 JUL 2009, DOI: 10.1002/ibd.20999

  4. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by Balsalazide and VSL#3

    Journal of Gastroenterology and Hepatology

    Accepted manuscript online: 29 DEC 2015, Eun-ju Do, Sung Wook Hwang, Sang-Yeob Kim, Yeon-Mi Ryu, Eun A Cho, Eun-Ju Chung, Sunha Park, Hyo Jeong Lee, Jeong-Sik Byeon, Byong Duk Ye, Dong-Hoon Yang, Sang Hyoung Park, Suk-Kyun Yang, Jin-Ho Kim and Seung-Jae Myung

    DOI: 10.1111/jgh.13280

  5. Clinical trial assessing VSL#3 for the treatment of anterior resection syndrome

    ANZ Journal of Surgery

    Volume 82, Issue 6, June 2012, Pages: 420–427, Jacqueline H. Stephens and Peter J. Hewett

    Version of Record online : 9 MAY 2012, DOI: 10.1111/j.1445-2197.2012.06082.x

  6. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics

    Inflammatory Bowel Diseases

    Volume 18, Issue 8, August 2012, Pages: 1424–1433, Rob Mariman, Bas Kremer, Marjan van Erk, Tonny Lagerweij, Frits Koning and Lex Nagelkerken

    Version of Record online : 11 DEC 2011, DOI: 10.1002/ibd.22849

  7. You have free access to this content
    Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

    Hepatology

    Volume 37, Issue 2, February 2003, Pages: 343–350, Zhiping Li, Shiqi Yang, Huizhi Lin, Jiawen Huang, Paul A. Watkins, Ann B. Moser, Claudio DeSimone, Xiao-yu Song and Anna Mae Diehl

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2003.50048

  8. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis

    Inflammatory Bowel Diseases

    Volume 17, Issue 1, January 2011, Pages: 289–297, Joshua M. Uronis, Janelle C. Arthur, Temitope Keku, Anthony Fodor, Ian M. Carroll, Myrella L. Cruz, Caroline B. Appleyard and Christian Jobin

    Version of Record online : 17 JUN 2010, DOI: 10.1002/ibd.21366

  9. Probiotics and the management of inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 3, May 2004, Pages: 286–299, Richard N. Fedorak and Karen L. Madsen

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200405000-00018

  10. Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis

    Inflammatory Bowel Diseases

    Volume 16, Issue 8, August 2010, Pages: 1286–1298, Siew C. Ng, Sophie Plamondon, Michael A. Kamm, Ailsa L. Hart, Hafid Omar Al-Hassi, Thomas Guenther, Andrew J. Stagg and Stella C. Knight

    Version of Record online : 12 FEB 2010, DOI: 10.1002/ibd.21222

  11. You have free access to this content
    Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy

    Allergy

    Volume 66, Issue 4, April 2011, Pages: 499–508, E. Schiavi, B. Barletta, C. Butteroni, S. Corinti, M. Boirivant and G. Di Felice

    Version of Record online : 8 NOV 2010, DOI: 10.1111/j.1398-9995.2010.02501.x

  12. Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: A pilot study

    Inflammatory Bowel Diseases

    Volume 15, Issue 5, May 2009, Pages: 760–768, Hien Q. Huynh, Jennifer deBruyn, Leluo Guan, Hugo Diaz, Meiju Li, Safwat Girgis, Justine Turner, Richard Fedorak and Karen Madsen

    Version of Record online : 9 DEC 2008, DOI: 10.1002/ibd.20816

  13. You have free access to this content
    A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 7, April 2003, Pages: 895–904, H. J. Kim, M. Camilleri, S. Mckinzie, M. B. Lempke, D. D. Burton, G. M. Thomforde and A. R. Zinsmeister

    Version of Record online : 26 MAR 2003, DOI: 10.1046/j.1365-2036.2003.01543.x

  14. Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites

    Liver International

    Volume 34, Issue 10, November 2014, Pages: 1504–1512, Diego Rincón, Javier Vaquero, Ana Hernando, Evelyn Galindo, Cristina Ripoll, Marta Puerto, Magdalena Salcedo, Rubén Francés, Ana Matilla, María V. Catalina, Gerardo Clemente, José Such and Rafael Bañares

    Version of Record online : 4 APR 2014, DOI: 10.1111/liv.12539

  15. You have free access to this content
    Probiotic supplementation attenuates increases in body mass and fat mass during high-fat diet in healthy young adults

    Obesity

    Volume 23, Issue 12, December 2015, Pages: 2364–2370, Kristin L. Osterberg, Nabil E. Boutagy, Ryan P. McMillan, Joseph R. Stevens, Madlyn I. Frisard, John W. Kavanaugh, Brenda M. Davy, Kevin P. Davy and Matthew W. Hulver

    Version of Record online : 14 OCT 2015, DOI: 10.1002/oby.21230

  16. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis

    Intervention Review

    The Cochrane Library

    Siddharth Singh, Andrea M Stroud, Stefan D Holubar, William J Sandborn and Darrell S Pardi

    Published Online : 23 NOV 2015, DOI: 10.1002/14651858.CD001176.pub3

  17. Etiology of pouchitis

    Inflammatory Bowel Diseases

    Volume 18, Issue 6, June 2012, Pages: 1146–1155, J. Landy, H.O. Al-Hassi, S.D. McLaughlin, S.C. Knight, P.J. Ciclitira, R.J. Nicholls, S.K. Clark and A.L. Hart

    Version of Record online : 21 OCT 2011, DOI: 10.1002/ibd.21911

  18. Variable response to probiotics in two models of experimental colitis in rats

    Inflammatory Bowel Diseases

    Volume 8, Issue 6, November 2002, Pages: 399–406, Dr. Oren Shibolet, Fanny Karmeli, Rami Eliakim, Erwin Swennen, Patrizia Brigidi, Paulo Gionchetti, Massimo Campieri, Sara Morgenstern and Daniel Rachmilewitz

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200211000-00004

  19. Probiotic administration in patients with ileal pouch–anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells

    Inflammatory Bowel Diseases

    Volume 14, Issue 5, May 2008, Pages: 662–668, Annamaria Pronio, Chiara Montesani, Cinzia Butteroni, Simona Vecchione, Gloria Mumolo, AnnaRita Vestri, Domenico Vitolo and Monica Boirivant

    Version of Record online : 31 JAN 2008, DOI: 10.1002/ibd.20369

  20. You have free access to this content
    Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 11, June 2014, Pages: 1276–1285, A. Alisi, G. Bedogni, G. Baviera, V. Giorgio, E. Porro, C. Paris, P. Giammaria, L. Reali, F. Anania and V. Nobili

    Version of Record online : 16 APR 2014, DOI: 10.1111/apt.12758